Prosecution Insights
Last updated: October 02, 2026

Examiner: BEVERIDGE, CONNOR HAMMOND

Tech Center 4100 • Art Units: 1687 2147 2151 4100

This examiner grants 0% of resolved cases

Analysis

Connor Hammond Beveridge is an examiner in Tech Center 4100, assigned to Art Unit 1687. The current data shows 1 resolved case for this examiner. This 1 resolved case resulted in an allowance rate of 0.0 percent. Because the data set is limited to 1 resolved case, practitioners should view this 0.0 percent allowance rate as a preliminary figure. The statistical profile for this examiner in Art Unit 1687 is currently based on this single outcome.

The median days to allowance is recorded at 1526. This 1526-day figure represents the duration for the single resolved case in the examiner's history. Additionally, the interview lift is currently 0.0 percent. This 0.0 percent lift indicates that, in the 1 resolved case processed, an interview was not associated with an allowance. The 1526 median days to allowance provides the only available timeline for a resolved case under this examiner.

In Tech Center 4100, the 1 resolved case and 0.0 percent allowance rate constitute the current data. The 1526 median days to allowance and 0.0 percent interview lift are the benchmarks available for Art Unit 1687. Practitioners should monitor future resolutions to see if the 0.0 percent allowance rate and 0.0 percent interview lift change as more cases are processed. The 1526-day duration remains the sole point of reference for pendency.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

0.0%
Allow Rate
-60.0% vs TC avg
21
Total Applications
+0.0%
Interview Lift
1526
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

30.1%
§101 Eligibility
3.3%
§102 Novelty
59.5%
§103 Obviousness
6.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17850722 SYSTEM AND METHOD FOR ESTIMATING SOLUBILITY Final Rejection SAMSUNG ELECTRONICS CO., LTD.
18030432 INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM Non-Final OA NEC Corporation
18352213 INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, PROGRAM, AND DRUG EVALUATION METHOD Non-Final OA FUJIFILM CORPORATION
17833719 METHODS, SYSTEMS, AND TOOLS FOR LONGEVITY-RELATED APPLICATIONS Non-Final OA Genentech, Inc.
18088151 Inverse Modeling for Characteristic Prediction from Multi-Spectral and Hyper-Spectral Remote Sensed Datasets Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
17836250 STORAGE MEDIUM, SEARCH METHOD, AND SEARCH DEVICE Final Rejection FUJITSU LIMITED
18049799 SYSTEMS AND METHODS FOR A PET RELATIVE FINDER Final Rejection Mars, Incorporated
18023135 SURGICAL PHASE RECOGNITION WITH SUFFICIENT STATISTICAL MODEL Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
17932212 CLASSIFICATION USING A MACHINE LEARNING MODEL TRAINED WITH TRIPLET LOSS Non-Final OA MICROSOFT TECHNOLOGY LICENSING, LLC
18457592 SYSTEM AND METHOD FOR PREDICTING MONOMERIC HEAD AND TAIL POSITIONS IN POLYMERIZATION AND RETROSYNTHESIS Non-Final OA International Business Machines Corporation
17805241 ARTIFICIAL PHOTOSYNTHESIS OPTIMIZATION Final Rejection INTERNATIONAL BUSINESS MACHINES CORPORATION
17758836 METHOD FOR PREDICTING CELL SPATIAL RELATION BASED ON SINGLE-CELL TRANSCRIPTOME SEQUENCING DATA Final Rejection PEKING UNIVERSITY
17888644 DATA ANALYSIS SYSTEM, DATA ANALYSIS METHOD, AND COMPUTER PROGRAM Non-Final OA SHIMADZU CORPORATION
18082157 SYSTEMS AND METHODS FOR DECONVOLUTION OF EXPRESSION DATA Non-Final OA BostonGene Corporation
18243320 USING BIPARTITE NETWORKS TO DETERMINE INTERACTIONS BETWEEN ANALYTES AND CHEMICAL TREATMENTS Non-Final OA UT-Battelle, LLC
18038650 COMPUTER-IMPLEMENTED METHOD FOR PREPARING OLIGONUCLEOTIDES USED TO DETECT NUCLEOTIDE MUTATION OF INTEREST Non-Final OA SEEGENE, INC.
18249826 METHOD FOR PERFORMANCE EVALUATION OF A DETERGENT COMPOSITION Non-Final OA Novozymes A/S
17837642 DETERMINING PATHOGENIC RFC1 EXPANSIONS FROM SEQUENCING DATA Non-Final OA Illumina, Inc.
18140095 AGENTS BINDING MODIFIED ANTIGEN PRESENTED PEPTIDES AND USE OF SAME Non-Final OA Yeda Research and Development Co. Ltd.
18030889 METHODS, SYSTEMS AND DEVICES FOR PROCESSING SEQUENCE DATA Non-Final OA Bruker Spatial Biology, Inc.
18361023 METHYLATION-BASED AGE PREDICTION AS FEATURE FOR CANCER CLASSIFICATION Non-Final OA GRAIL, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month